Results 81 to 90 of about 919,117 (202)
Preoperative Serum Placenta Growth Factor Level Is a Prognostic Biomarker in Colorectal Cancer
, 2011 PURPOSE: Increased angiogenesis at the site of the primary tumor in colorectal cancer has been associated with poor prognosis and relapse of disease. We previously demonstrated that the tissue level of placenta growth factor expression was upregulated in
WEI, SHU-CHEN;LIANG, JIN-TUNG;TSAO, PO-NIEN;HSIEH, FON-JOU;YU, SENG-CHANG;WONG, JAU-MIN +1 more
core +1 more source
European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions
Molecular Oncology, Volume 20, Issue 1, Page 96-116, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts +18 more
wiley +1 more source
, 1999 Background & Aims: CagA-positive Helicobacter pylori infection has been more closely associated with gastric disease than CagA-negative infection. This study evaluated whether geographic variation in the prevalence of CagA could explain variation in ...
FORMAN, D +6 more
core +1 more source
Food Frontiers, Volume 7, Issue 1, January 2026.ABSTRACT Gastrointestinal diseases remain a significant global health concern, primarily due to the limitations of current pharmacological treatments, which often come with adverse side effects and high recurrence rates. This situation highlights the urgent need for safer and more effective alternatives.
Isabel Sousa Alcântara +7 more
wiley +1 more source
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma [PDF]
, 2011 Background: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies ...
Polta, Andreas +55 more
core +2 more sources
A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage [PDF]
, 2008 For the generation of cell-based therapeutic products, it would be preferable to avoid the use of animal-derived components. Our study thus aimed at investigating the possibility to replace foetal bovine serum (FBS) with autologous serum (AS) for the ...
Farhadi, J. +11 more
core +1 more source
Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B [PDF]
, 2005 Background: HBV infection is a serious global heath problem. It is crucial to monitor this disease more closely with a non-invasive marker in clinical trials.
Montazeri, G. +30 more
core +2 more sources
, 1961 Letter from Swiss Serum and Vaccine Institute Berne to Sabin, Albert B.
Swiss Serum and Vaccine Institute Berne
core +1 more source
Erythropoiesis, serum erythropoietin, and serum IGF-I in rats during accelerated growth [PDF]
, 1990 In this study we have examined the correlation between activity of erythropoiesis and serum concentrations of erythropoietin and insulin-like growth factor I in male and female rats during accelerated growth (day 30-90).
Kurtz, Armin +3 more
core +1 more source
Immunochemical characterization and cellular localization of pepsinogens in cat and dog.
, 1978 The antigenic relationships and cellular localization of cat and dog pepsinogens were investigated by electrophoretic analysis, immunodiffusion, immunoelectrophoresis, immunoabsorption, and by immunofluorescence, respectively.
W M Liebman, I M Samloff
core +1 more source